Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Adolor and SmithKline Beecham sign licensing agreement for ADL-2-1294

July 29, 1999

Patient enrollment completed in Anogesic phase III trial

July 27, 1999

IDE granted to Gliatech for ADCON-A

July 22, 1999

Nonsteroidal Rx for atopic dermatitis enters late-stage clinical trials in U.S.

July 13, 1999

Positive results from phase II psoriasis study of hu1124 presented at dermatology meeting

July 8, 1999

Abgenix and Japan Tobacco enter collaboration for ABX-IL-8 development

July 2, 1999

Dusa receives FDA approvable letter for Levulan NDA

June 30, 1999

Preclinical profile suggests that cipamfylline is a promising candidate for atopic dermatitis

June 29, 1999

Ferrer to market Ortec's Composite Cultured Skin in Spain

June 29, 1999

Leo and SB present new p38 MAP kinase inhibitor with topical antiinflammatory activity

June 28, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...